Drug Profile
Mosapride sustained release - Daewoong Pharmaceutical
Alternative Names: DWJ 1252Latest Information Update: 23 Feb 2022
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Antiulcers; Benzamides; Gastrokinetics; Morpholines; Small molecules
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Dyspepsia
Most Recent Events
- 23 Feb 2022 Discontinued - Phase-III for Dyspepsia in South Korea (PO)
- 18 Apr 2017 Daewoong Pharmaceutical initiates enrolment in a phase III trial for Dyspepsia in South Korea (NCT03184402)
- 15 Feb 2017 Chemical structure information added